12: 16-year-old female with vaginal bleeding and UCG Flashcards
Chlamydia: Epidemiology, Course of Disease, & Screening Recommendations
Epidemiology
Chlamydial infection is the most common sexually transmitted bacterial infection in the United States. In 2007, more than 1.1 million chlamydia cases were reported to the CDC. It is thought that another million cases of chlamydia remain unreported.
Course of disease
Chlamydia is often insidious and asymptomatic. In women, genital chlamydial infection may result in urethritis, cervicitis, pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. Chlamydial infection during pregnancy is related to adverse pregnancy outcomes including miscarriage, premature rupture of membranes, preterm labor, low birth weight, and infant mortality.
Screening recommendations
The USPSTF found fair evidence that nucleic acid amplification tests (NAATs) can identify chlamydial infection in asymptomatic men and women, including asymptomatic pregnant women, with high test specificity. In low prevalence populations, however, a positive test is more likely to be a false positive than a true positive, even with the most accurate tests available.
Qualities of a Good Screening Test
- The condition should be an important health problem and the condition screened for must have a high prevalence in the population.
- There should be a latent stage of the disease.
3. There should also be effective treatment for the condition being screened.
- Facilities for diagnosis and treatment should be available.
- There should be a test or examination for the condition.
- The test should be acceptable to the population and the total cost of finding a case should be economically
balanced in relation to medical expenditure as a whole. The potential benefits of early detection and treatment of a condition need to be weighed against many factors including: adverse side effects of the screening test, time and effort required (of both the patient and the healthcare system) to take the test, financial cost of the test, potential psychological and physical harm of false positive results (such as labeling and overtreatment), adverse effects of the treatment. - The natural history of the disease should be adequately understood.
- There should be an agreed policy on who to treat.
- Case-finding should be a continuous process, not just a “once and for all” project.
- An effective screening test should have very good sensitivity (identify most or all potential cases) and specificity (label incorrectly as few as possible as potential cases). Even a test with a sensitivity of 95% will lead to many false positives when the prevalence of the condition is very low.
United States Preventive Services Task Force Recommendations for Chlamydia Screening
The USPSTF recommends screening for chlamydia infection in the following B):
- -All sexually active women age 24 and younger
- -Sexually active women age 25 and older who are at increased risk
Rationale: There is direct evidence that screening reduces complications of chlamydial infection in women who are at increased risk, with a moderate magnitude of benefit. Such complications include pelvic inflammatory disease, infertility, and premature delivery (among pregnant women)
United States Preventive Services Task Force Recommendations for Chlamydia Screening
The USPSTF advises against screening women age 25 and older if not at increased risk, regardless of pregnancy status.
Only the above categories are found to have a high enough pretest probability to recommend screening. Women (pregnant or non-pregnant) in general are not recommended for chlamydial screening as the overall benefit of screening would be small, given the low prevalence of infection among women not at increased risk.
Risk factors for chlamydial infection include a history of chlamydial or other sexually transmitted infection, new or multiple sexual partners, inconsistent condom use, and exchanging sex for money or drugs. Risk factors for pregnant women are the same as for nonpregnant women.
Finally, the USPSTF states that there is “Insufficient” evidence for or against screening men.
Counsel all sexually active adolescents regarding contraception.
Options include: oral contraceptives, medroxyprogesterone (Depo-Provera) injections, transdermal options, IUDs, and the vaginal ring (NuvaRing)
Remind patients these options do not protect against sexually transmitted infections
Discuss condoms and abstinence
Recommend folic acid supplementation to prevent neural tube defects in the event of pregnancy
Preconception Counseling
Finding the opportunity to do preconception counseling in situations where the woman does not take the initiative to schedule a preconception visit can be difficult. Whether it is walk-in / urgent care visits, sports pre-participation examinations, or adolescent well-child exams, the following list should be “on your radar screen” to effectively avail yourself of often scarce opportunities to advise women in these preconception issues.
Preconception Health Care Checklist:
Genetic
»Folic acid supplement (400 mcg routine):
—The USPSTF recommends that all women “planning or capable of pregnancy” take a daily supplement containing 400 - 800 mcg of folic acid.
—-The dose is increased for the following high-risk scenarios:
A. 1 mg in patients with diabetes or epilepsy
B. 4 mg in patients who bore a child with a previous neural tube defect
> > Carrier screening (ethnic background):
- —sickle cell anemia
- —thalassemia
- —Tay-Sachs disease
> > Carrier screening (family history):
- —cystic fibrosis
- —nonsyndromic hearing loss (connexin-26)
Screen for infectious diseases, treat, immunize, counsel
>HIV
>Syphilis
>Hepatitis B immunization
>Preconception immunizations (rubella, varicella)
>Toxoplasmosis-avoid cat litter, garden soil, raw meat
>Cytomegalovirus, parvovirus B19 (fifth disease)-frequent hand washing, universal precautions for child care and health care
Environmental toxins
>Occupational exposures: Material Safety Data Sheets from employer
>Household chemicals: avoid paint thinners and strippers, other solvents, pesticides >Smoking cessation: bupropion (Zyban), nicotine patches (Nicoderm)
>Screen for alcoholism and use of illegal drugs
Medical assessment
>Diabetes: optimize control, folic acid, 1 mg per day, off ACE-inhibitors
>Hypertension: avoid ACE inhibitors, angiotensin II receptor antagonists, thiazide diuretics
>Epilepsy: optimize control; folic acid, 1 mg per day
>DVT: switch from warfarin (Coumadin) to heparin
>Depression/anxiety: avoid benzodiazepines
Lifestyle
>Recommend regular moderate exercise >Avoid hyperthermia (hot tubs, overheating
>Caution against obesity and being underweight
>Screen for domestic violence
>Assess risk of nutritional deficiencies (vegan, pica, milk intolerance, calcium or iron deficiency)
>Avoid overuse of Vitamin A (recommendations are to 750 mcg (2500 IU per day) with daily upper intake limit of 3,000 mcg (10,000 IU))
>Avoid overuse of Vitamin D (recommendations are 600 IU per day, tolerable upper intake is 4000 IU) Caffeine (limit to the equivalent of two cups of coffee or six glasses of soda per day)
»Note: The sugar intake in six glasses of soda is not recommended.
Signs and Symptoms of Pregnancy
Amenorrhea with fatigue, nausea, and/or vomiting as well as breast changes, including tenderness, are the classic presentations of pregnancy.
Urinary frequency can also occur. Although urinary frequency can be a normal symptom of pregnancy, the possibility of a UTI in a pregnant woman should also be considered.
Softening of the cervix is known as Goodell’s sign, while softening of the uterus is known as Hegar’s sign.
The bluish-purple hue in the cervix and vaginal walls is known as Chadwick’s sign and is caused by hyperemia.
Enlargement of the uterus can be detected by an experienced examiner as early as 8 weeks on bimanual exam. Around 12 weeks, the uterine fundus can be palpated above the symphysis pubis. Between 20 to 36 weeks of gestation, the uterine enlargement, measured in centimeters, approximates gestational age and will become a routinely elicited physical exam finding.
Fetal heart tones are typically elicited by hand-held Doppler between 10-12 weeks gestation.
Fetal movement or “quickening” is detected by the mother around 18-20 weeks of gestation.
Unfortunately, the menstrual history is not an entirely reliable indicator of pregnancy. Only 68% of pregnant adolescents report having missed a menses. Conversely, not every adolescent who misses a menses is pregnant because anovulatory cycles are normal in the early postmenarcheal years. Bleeding can occur in early pregnancy around the time of the missed menses as a result of an invasion of the trophoblast into the decidua (implantation bleed). Some adolescents mistake this bleeding for a menses, leading to a delay in diagnosis of pregnancy and potential misdating of the pregnancy. We should also remember that young women who have not yet menstruated, but are sexually active, may be at risk for pregnancy because ovulation can occasionally occur before the first menstrual period.
Reproductive Choice Counseling
Continue the pregnancy…
…and raise the child.
…and create an adoption plan.
Terminate the pregnancy…
…medically
…surgically
Calculating the Estimated Gestational Age (EGA)
based on the Last Normal Menstrual Period (LNMP). Calculating the EGA in this manner is not only convenient but ubiquitous in clinical practice. Keep in mind, however, that the actual embryonic age (e.g., the age of the fetus since the date of conception) will typically be approximately two weeks less than the clinically calculated EGA based upon the LNMP.
The other calculation used in clinical practice - which patients care a great deal about - is the Estimated Due Date.
Calculating the estimated due date (EDD - sometimes referred to as the estimated date of confinement or EDC) from the last menstrual period is a relatively simple process that can be done with an obstetric “wheel”, with an electronic calculator (e.g., http://www.mdcalc.com/pregnancy-due-dates-calculator ) or using Naegele’s Rule.
Naegele’s Rule is commonly described as starting with the first day of the last normal menstrual period, then:
»add 1 year
»subtract 3 months
»add 1 week
For example, if a patient’s LNMP was 7/10/2009, then:
7/10/2010 (+1 yr)
4/10/2010 (-3 mo)
4/17/2010 (+1 wk)
Thus, the EDD is 4/17/2010.
Hemodynamic Instability
Typically, a significant bleed will first cause the pulse to rise and then the blood pressure to drop. Despite the fact that blood pressure is normal, bleeding can continue for a while before the blood pressure reflects this. This finding really changes how urgently you need to begin to make your assessment and, in some cases, intervene.
Rhesus immune globulin (RhoGam)
Rho(D) Immune Globulin is a critical part of modern obstetrics. Prior to the clinical use of this medication, Rh- negative mothers with Rh-positive first gestations were at high risk of having subsequent gestations and developing hemolytic anemia, hydrops, and/or fetal death. With every pregnancy, there is some passage of fetal red blood cells into the maternal circulation. This occurs at either miscarriage or delivery and can even occur in small but significant quantities across the otherwise placental barrier.
When a mother with an intact immune system detects enough of the fetal Rho-D antigen, she forms antibodies to this antigen. This immune response is usually not robust enough to impact the first gestation, but subsequent gestations are at significant risk of an immune response. When this occurs, the maternal antibodies attack the fetus’ red blood cells, causing hemolytic anemia, which can lead to fetal hydrops and even fetal death.
Rho(D) Immune Globulin administered at appropriate times interrupts the maternal immunologic process. You can visualize this process by imagining the RhoGAM attaching to all of the fetal Rho-D antigenic load, making it immunologically “invisible” to the maternal immune system.
First Trimester Vaginal Bleeding
One in four pregnant patients experience vaginal bleeding during the first trimester.
When women have significant bleeding in the first trimester, there is a 25-50% chance of miscarriage.
Ectropion
When the central part of the cervix appears red from the mucous-producing endocervical epithelium protruding through the cervical os, onto the face of the cervix. It has no clinical significance and is common in women who are taking oral contraceptive pills.